Related Experiment Videos
Pyridoxol metabolism in vitamin B6-responsive convulsions of early infancy
Insights
Vitamin B6-responsive convulsions may stem from an unstable pyridoxal phosphate-albumin complex, hindering sustained plasma levels. This metabolic defect affects vitamin B6 processing in affected individuals.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Neuroscience
Background:
- Investigating the metabolic defect in vitamin B6-responsive convulsions is crucial due to clinical uncertainties.
- Pyridoxal metabolism was studied in patients with suspected vitamin B6-responsive convulsions.
Observation:
- Plasma pyridoxal phosphate (PALP) levels rose initially but fell rapidly after pyridoxol loading in patients.
- Urinary excretion of 4-pyridoxic acid was normal, but pyridoxol excretion increased post-load.
- Biochemical findings were also noted in an infant with neonatal convulsions without clinical B6 dependency.
Findings:
- Patients with vitamin B6-responsive convulsions appear capable of normal PALP synthesis.
- The primary issue seems to be an inability to maintain elevated plasma PALP levels.
- Increased urinary pyridoxol excretion suggests a potential defect in PALP stabilization.
Implications:
- The findings suggest a possible instability of the PALP-albumin complex in vitamin B6-responsive convulsions.
- This could indicate a novel mechanism contributing to certain types of seizures.
- Further research is needed to confirm the role of PALP-albumin complex stability in neurological conditions.
Abstract:
As there is uncertainty about the nature of the metabolic defect in vitamin B6-responsive convulsion, certain aspects of pyridoxol metabolism were studied in 3 patients who were believed on clinical grounds to have the condition. The findings were compared with those in healthy children and adults, and in children with mental handicap. The magnitude of the initial rise and the subsequent fall in plasma pyridoxal phosphate (PALP) concentrations after a load of pyridoxol suggested that the vitamin B6-responsive patients were able to synthesise PALP normally but were unable to maintain the prolonged high levels normally found in plasma. The urinary excretion of 4-pyridoxic acid was within normal limits, but the excretion of pyridoxol after the load was raised. It is suggested that there may be an instability of the PALP-albumin complex in this condition. Some of the biochemical features were also observed in an infant presenting with convulsions soon after birth but without evidence of clinical B6-dependency.